Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 2
1996 3
1998 1
2000 1
2001 1
2002 4
2003 4
2004 9
2005 5
2006 9
2007 5
2008 14
2009 15
2010 12
2011 9
2012 9
2013 6
2014 3
2015 5
2016 3
2017 6
2018 2
2020 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
Gao H, Korn JM, Ferretti S, Monahan JE, Wang Y, Singh M, Zhang C, Schnell C, Yang G, Zhang Y, Balbin OA, Barbe S, Cai H, Casey F, Chatterjee S, Chiang DY, Chuai S, Cogan SM, Collins SD, Dammassa E, Ebel N, Embry M, Green J, Kauffmann A, Kowal C, Leary RJ, Lehar J, Liang Y, Loo A, Lorenzana E, Robert McDonald E 3rd, McLaughlin ME, Merkin J, Meyer R, Naylor TL, Patawaran M, Reddy A, Röelli C, Ruddy DA, Salangsang F, Santacroce F, Singh AP, Tang Y, Tinetto W, Tobler S, Velazquez R, Venkatesan K, Von Arx F, Wang HQ, Wang Z, Wiesmann M, Wyss D, Xu F, Bitter H, Atadja P, Lees E, Hofmann F, Li E, Keen N, Cozens R, Jensen MR, Pryer NK, Williams JA, Sellers WR. Gao H, et al. Among authors: atadja p. Nat Med. 2015 Nov;21(11):1318-25. doi: 10.1038/nm.3954. Epub 2015 Oct 19. Nat Med. 2015. PMID: 26479923
Epigenetics in cancer: targeting chromatin modifications.
Ellis L, Atadja PW, Johnstone RW. Ellis L, et al. Among authors: atadja pw. Mol Cancer Ther. 2009 Jun;8(6):1409-20. doi: 10.1158/1535-7163.MCT-08-0860. Epub 2009 Jun 9. Mol Cancer Ther. 2009. PMID: 19509247 Review.
HDAC inhibitors and cancer therapy.
Atadja PW. Atadja PW. Prog Drug Res. 2011;67:175-95. doi: 10.1007/978-3-7643-8989-5_9. Prog Drug Res. 2011. PMID: 21141730 Review.
Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC Interaction.
Ding J, Li G, Liu H, Liu L, Lin Y, Gao J, Zhou G, Shen L, Zhao M, Yu Y, Guo W, Hommel U, Ottl J, Blank J, Aubin N, Wei Y, He H, Sage DR, Atadja PW, Li E, Jain RK, Tallarico JA, Canham SM, Chiang YL, Wang H. Ding J, et al. Among authors: atadja pw. ACS Chem Biol. 2023 Jan 20;18(1):34-40. doi: 10.1021/acschembio.2c00843. Epub 2023 Jan 3. ACS Chem Biol. 2023. PMID: 36594833
Loss of Wdr5 attenuates MLL-rearranged leukemogenesis by suppressing Myc targets.
Liu L, Guo X, Wang Y, Li G, Yu Y, Song Y, Zeng C, Ding Z, Qiu Y, Yan F, Zhang YX, Zhao C, Zhang Y, Dou Y, Atadja P, Li E, Wang H. Liu L, et al. Among authors: atadja p. Biochim Biophys Acta Mol Basis Dis. 2023 Feb;1869(2):166600. doi: 10.1016/j.bbadis.2022.166600. Epub 2022 Nov 17. Biochim Biophys Acta Mol Basis Dis. 2023. PMID: 36402263 Free article.
125 results